BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 8, 2021
View Archived Issues
Phase II trial evaluates CBP-201 for chronic rhinosinusitis with nasal polyps
Read More
FDA approves IND for phase I study of STP-707 in solid tumors
Read More
AstraZeneca initiates phase I/II study of AZD-0466 in advanced hematological malignancies
Read More
Novartis studies combination of VOB-560 and MIK-665 for advanced hematological malignancies
Read More
New TGF-beta inhibitor KS-356 improves experimental obesity, hepatic steatosis
Read More
Dual GIP/GLP-1 receptor agonist HISHS-2001 displays efficacy in type 2 diabetes model
Read More
Scientists describe new model of primary sclerosing cholangitis-associated cholangiocarcinoma
Read More
SciSparc to initiate phase II study of SCI-110 in patients with AD and agitation
Read More
Chinese researchers patent claudin 18.2-targeting ADCs
Read More
Roche discloses BRAF mutant inhibitors
Read More
Shaanxi Synthetic Pharmaceutical identifies new antibacterials
Read More
Chiesi Farmaceutici synthesizes new LPAR2 antagonists
Read More
Centivax patents CR-3022-derived antibodies for SARS-CoV-2
Read More
Researchers at University of Oxford initiate phase I study of HIVconsvX vaccine
Read More
To close or not to close: Astrocytes influence brain plasticity by controlling critical period
Read More
LY-3305677 is safe and shows body weight-lowering effect in FIH trial
Read More
CXD-101 demonstrates promising early clinical data in its China IND program
Read More
Atossa receives approval to open phase I/II study of AT-H201 in Australia
Read More
Dosing starts in phase I/II study of Moderna's quadrivalent seasonal flu mRNA vaccine
Read More
FDA clears IND for ASC-618 gene therapy for hemophilia A
Read More
AXA-1125 enhances insulin sensitivity in subjects with NAFLD and T2D
Read More
Ischemix awarded DoD funding to support phase I study of CMX-2043 for traumatic brain injury
Read More
Alterations in GRK5 disrupt cardiac function in murine model
Read More
Ysopia completes phase I study of Xla-1 for obesity and metabolic diseases
Read More
Batavia collaborates with RocketVax on SARS-CoV-2 vaccine candidate
Read More